Page last updated: 2024-10-23

bisbenzimidazole and Dyskinesia, Drug-Induced

bisbenzimidazole has been researched along with Dyskinesia, Drug-Induced in 1 studies

Bisbenzimidazole: A benzimidazole antifilarial agent; it is fluorescent when it binds to certain nucleotides in DNA, thus providing a tool for the study of DNA replication; it also interferes with mitosis.

Dyskinesia, Drug-Induced: Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of the face, trunk, neck, and extremities are most commonly affected. Tardive dyskinesia refers to abnormal hyperkinetic movements of the muscles of the face, tongue, and neck associated with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS). (Adams et al., Principles of Neurology, 6th ed, p1199)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zang, XP1
Tanii, H1
Kobayashi, K1
Higashi, T1
Oka, R1
Koshino, Y1
Saijoh, K1

Other Studies

1 other study available for bisbenzimidazole and Dyskinesia, Drug-Induced

ArticleYear
Behavioral abnormalities and apoptotic changes in neurons in mice brain following a single administration of allylnitrile.
    Archives of toxicology, 1999, Volume: 73, Issue:1

    Topics: Animals; Apoptosis; Behavior, Animal; Bisbenzimidazole; Brain; Caspase 3; Caspases; DNA Fragmentatio

1999